Synthesis and Research Anticonvulsant Activity of Annulated Triazolo-Thiadiazine Derivative in Laboratory Animals
Authors:
- Zafar Isomiddinovich SanoevZSZafar Isomiddinovich Sanoev
- Dilnoza Safaralievna IsmailovaDIDilnoza Safaralievna Ismailova
- Sukhrob Davlatyor Ogli RakhimboevSRSukhrob Davlatyor Ogli Rakhimboev
- Tolmas Tolibovich KhamroevTKTolmas Tolibovich Khamroev
- Burkhon Zhuraevich ElmuradovBEBurkhon Zhuraevich Elmuradov
- Ibrokhimjon Tuychievich AbdinazarIAIbrokhimjon Tuychievich Abdinazar
- Sokhib Zamon Ogli RashidovSRSokhib Zamon Ogli Rashidov
Open Access
- 31 December 2023
- journal article
- research article
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 16 (4) , 2457-2467
Abstract
Epilepsy is a chronic non-communicable disease of the brain, which is estimated that five million people are diagnosed with epilepsy every year worldwide. In this regard the study studied the anticonvulsant properties of annulated 4-(6-phenyl-7H-[1,2,4] triazolo [3,4-b] [1,3,4] thiadiazin-3-yl)-aniline. Anticonvulsant activity was evaluated in various experimental models of convulsions in laboratory rodents. Oral dosages of 3, 10, 30, and 60 mg/kg of the study substances were given one hour prior to the experiment. Pentylenetetrazole (PTZ) convulsions were modeled using PTZ at a dose of 7 mg/kg subcutaneously, isoniazid convulsions were modeled using an oral dose of 300 mg/kg, and bicuculline convulsions were modeled using a subcutaneous dose of 2,7 mg/kg. Also, comparatively studied the antiepileptic activity of triazole derivatives with the well-known antiepileptic drug carbamazepine. In the conducted studies the studied compound showed carbamazepine-like activity at doses of 3 and 10 mg/kg in the model of seizures caused by strychnine, while at a dose of 30 mg/kg it showed high activity and in models induced using bicuculin and isoniazid, the studied drug showed activity similar to carbamazepine. On the contrary, the model of seizures induced by PTZ showed high activity at doses of 3, 10 and 30 mg/kg. The results obtained showed that triazole derivative had a pronounced antiepileptic activity, and further study can be proposed as a potential antiepileptic drug.Keywords
This publication has 32 references indexed in Scilit:
- Anticonvulsant Activity of B2, an Adenosine Analog, on Chemical Convulsant-Induced SeizuresPLOS ONE, 2013
- Synthesis, characterization and preliminary anticonvulsant evaluation of some 4-alkyl-1,2,4-triazolesEuropean Journal of Medicinal Chemistry, 2013
- Update to the AASM Clinical Practice Guideline: “The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder in Adults—An Update for 2012: Practice Parameters with an Evidence-Based Systematic Review and Meta-Analyses”SLEEP, 2012
- The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndromeJournal of Clinical Pharmacy and Therapeutics, 2009
- Synthesis of some new 4-styryltetrazolo[1,5-a]quinoxaline and 1-substituted-4-styryl[1,2,4]triazolo[4,3-a]quinoxaline derivatives as potent anticonvulsantsEuropean Journal of Medicinal Chemistry, 2009
- Toxicology case of the month: carbamazepine overdoseEmergency Medicine Journal, 2006
- Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in miceNeuropharmacology, 1989
- Functional anatomy of pentylenetetrazol and electroshock seizures in the rat brainstemAnnals of Neurology, 1987
- Potential Broad Spectrum Anthelmintics IV: Design, Synthesis, and Antiparasitic Screening of Certain 3,6-Disubstituted- (7H) -s -triazolo- [3,4-b][1,3,4]thiadiazine DerivativesJournal of Pharmaceutical Sciences, 1983
- Emotional behavior in the rat. III. The relationship between emotionality and ambulatory activity.Journal of Comparative Psychology, 1936